Drug Shortage Report for NAT-LEVETIRACETAM
| Report ID | 81921 |
| Drug Identification Number | 02440229 |
| Brand name | NAT-LEVETIRACETAM |
| Common or Proper name | LEVETIRACETAM Tablets |
| Company Name | NATCO PHARMA (CANADA) INC |
| Market Status | MARKETED |
| Active Ingredient(s) | LEVETIRACETAM |
| Strength(s) | 750MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 120 |
| ATC code | N03AX |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | 2019-08-01 |
| Actual start date | |
| Estimated end date | |
| Actual end date | 2021-10-14 |
| Shortage status | Resolved |
| Updated date | 2021-10-15 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2000 ARGENTIA ROAD, PLAZA 1, SUITE 200 MISSISSAUGA, ONTARIO CANADA L5N 1P7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2021-10-15 | English | Compare |
| v7 | 2021-10-14 | French | Compare |
| v6 | 2021-10-14 | English | Compare |
| v5 | 2021-10-14 | French | Compare |
| v4 | 2021-10-14 | English | Compare |
| v3 | 2019-08-02 | English | Compare |
| v2 | 2019-04-17 | French | Compare |
| v1 | 2019-04-17 | English | Compare |
Showing 1 to 8 of 8